Asia Pacific Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Theranostics Market would witness market growth of 16.2% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $351.8 million by 2030. The Japan market is registering a CAGR of 15.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 17% during (2023 - 2030).

Imaging modalities such as functional MRI (fMRI), diffusion tensor imaging (DTI), and amyloid PET imaging enable visualization of brain structure, function, and pathology, aiding in diagnosing and monitoring neurodegenerative diseases. Biomarker-based assays, including cerebrospinal fluid (CSF) analysis and neuroimaging markers, provide diagnostic and prognostic information for neurologic conditions. Theranostic approaches help identify therapeutic targets and guide personalized treatment strategies for neurological disorders, facilitating early intervention and disease modification.

Theranostics are increasingly being explored for diagnosing and managing infectious diseases, including bacterial, viral, and fungal infections. Diagnostic techniques such as nucleic acid amplification tests (NAATs), serological assays, and imaging modalities enable rapid and accurate detection of infectious agents and assessment of disease severity. Theranostic approaches help identify antimicrobial resistance patterns, guide antibiotic stewardship initiatives, and optimize antimicrobial therapy for infectious diseases.

The expansion of healthcare expenditure in Australia enables greater access to advanced diagnostic and therapeutic technologies, including these, for patients nationwide. According to data released by the Australian government, the nation spent an estimated $241.3 billion, or almost $9,365 per person, on health-related products and services in 2021–2022. The total amount spent on recurrent and capital health care increased by 6.0% in real terms (adjusted for inflation) compared to 2020–21. Thus, the increasing expenditure in the healthcare sector and the growing elderly population drive the market’s growth.

Free Valuable Insights: The Global Theranostics Market is Predict to reach USD 5.4 Billion by 2030, at a CAGR of 15.2%

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Bayer AG
• GE HealthCare Technologies, Inc.
• Siemens Healthineers AG (Siemens AG)
• Cardinal Health, Inc.
• Canon, Inc.
• Clarity Pharmaceuticals Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific, Inc.
• Telix Pharmaceuticals Limited
• ABX advanced biochemical compounds GmbH

Asia Pacific Theranostics Market Report Segmentation

By End User

• Hospitals & Cancer Care Centers
• Theranostics Centers
• Research & Academic Centers

By Product

• Radiopharmaceuticals
• Diagnostic Imaging
• IVD/Biomarker Screening
• Software & Services

By Application

• Prostate Cancer
• Bone Metastasis
• Other Cancers
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Theranostics Market, by End User
1.4.2 Asia Pacific Theranostics Market, by Product
1.4.3 Asia Pacific Theranostics Market, by Application
1.4.4 Asia Pacific Theranostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Asia Pacific Theranostics Market by End User
4.1 Asia Pacific Hospitals & Cancer Care Centers Market by Country
4.2 Asia Pacific Theranostics Centers Market by Country
4.3 Asia Pacific Research & Academic Centers Market by Country

Chapter 5. Asia Pacific Theranostics Market by Product
5.1 Asia Pacific Radiopharmaceuticals Market by Country
5.2 Asia Pacific Diagnostic Imaging Market by Country
5.3 Asia Pacific IVD/Biomarker Screening Market by Country
5.4 Asia Pacific Software & Services Market by Country

Chapter 6. Asia Pacific Theranostics Market by Application
6.1 Asia Pacific Prostate Cancer Market by Country
6.2 Asia Pacific Bone Metastasis Market by Country
6.3 Asia Pacific Other Cancers Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Theranostics Market by Country
7.1 China Theranostics Market
7.1.1 China Theranostics Market by End User
7.1.2 China Theranostics Market by Product
7.1.3 China Theranostics Market by Application
7.2 Japan Theranostics Market
7.2.1 Japan Theranostics Market by End User
7.2.2 Japan Theranostics Market by Product
7.2.3 Japan Theranostics Market by Application
7.3 India Theranostics Market
7.3.1 India Theranostics Market by End User
7.3.2 India Theranostics Market by Product
7.3.3 India Theranostics Market by Application
7.4 South Korea Theranostics Market
7.4.1 South Korea Theranostics Market by End User
7.4.2 South Korea Theranostics Market by Product
7.4.3 South Korea Theranostics Market by Application
7.5 Singapore Theranostics Market
7.5.1 Singapore Theranostics Market by End User
7.5.2 Singapore Theranostics Market by Product
7.5.3 Singapore Theranostics Market by Application
7.6 Malaysia Theranostics Market
7.6.1 Malaysia Theranostics Market by End User
7.6.2 Malaysia Theranostics Market by Product
7.6.3 Malaysia Theranostics Market by Application
7.7 Rest of Asia Pacific Theranostics Market
7.7.1 Rest of Asia Pacific Theranostics Market by End User
7.7.2 Rest of Asia Pacific Theranostics Market by Product
7.7.3 Rest of Asia Pacific Theranostics Market by Application

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Cardinal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Clarity Pharmaceuticals Ltd
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Telix Pharmaceuticals Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. ABX advanced biochemical compounds GmbH
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33 China Theranostics Market, 2019 - 2022, USD Million
TABLE 34 China Theranostics Market, 2023 - 2030, USD Million
TABLE 35 China Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36 China Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37 China Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38 China Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39 China Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40 China Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41 Japan Theranostics Market, 2019 - 2022, USD Million
TABLE 42 Japan Theranostics Market, 2023 - 2030, USD Million
TABLE 43 Japan Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44 Japan Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45 Japan Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46 Japan Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47 Japan Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48 Japan Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49 India Theranostics Market, 2019 - 2022, USD Million
TABLE 50 India Theranostics Market, 2023 - 2030, USD Million
TABLE 51 India Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52 India Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53 India Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54 India Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55 India Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56 India Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57 South Korea Theranostics Market, 2019 - 2022, USD Million
TABLE 58 South Korea Theranostics Market, 2023 - 2030, USD Million
TABLE 59 South Korea Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60 South Korea Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61 South Korea Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62 South Korea Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63 South Korea Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64 South Korea Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65 Singapore Theranostics Market, 2019 - 2022, USD Million
TABLE 66 Singapore Theranostics Market, 2023 - 2030, USD Million
TABLE 67 Singapore Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68 Singapore Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69 Singapore Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70 Singapore Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71 Singapore Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72 Singapore Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73 Malaysia Theranostics Market, 2019 - 2022, USD Million
TABLE 74 Malaysia Theranostics Market, 2023 - 2030, USD Million
TABLE 75 Malaysia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76 Malaysia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77 Malaysia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78 Malaysia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79 Malaysia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80 Malaysia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 83 Rest of Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85 Rest of Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87 Rest of Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Bayer AG
TABLE 90 Key Information – GE HealthCare Technologies, Inc.
TABLE 91 Key Information – Siemens Healthineers AG
TABLE 92 key information – Cardinal Health, Inc.
TABLE 93 Key Information – Canon, Inc.
TABLE 94 Key Information – Clarity Pharmaceuticals Ltd
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Thermo Fisher Scientific, Inc.
TABLE 97 Key Information – Telix Pharmaceuticals Limited
TABLE 98 Key Information – ABX advanced biochemical compounds GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Theranostics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Theranostics Market
FIG 4 Porter’s Five Forces Analysis - Theranostics Market
FIG 5 Asia Pacific Theranostics Market share by End User, 2022
FIG 6 Asia Pacific Theranostics Market share by End User, 2030
FIG 7 Asia Pacific Theranostics Market by End User, 2019 - 2030, USD Million
FIG 8 Asia Pacific Theranostics Market share by Product, 2022
FIG 9 Asia Pacific Theranostics Market share by Product, 2030
FIG 10 Asia Pacific Theranostics Market by Product, 2019 - 2030, USD Million
FIG 11 Asia Pacific Theranostics Market share by Application, 2022
FIG 12 Asia Pacific Theranostics Market share by Application, 2030
FIG 13 Asia Pacific Theranostics Market by Application, 2019 - 2030, USD Million
FIG 14 Asia Pacific Theranostics Market share by Country, 2022
FIG 15 Asia Pacific Theranostics Market share by Country, 2030
FIG 16 Asia Pacific Theranostics Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Bayer AG
FIG 18 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 19 SWOT Analysis: Siemens Healthineers AG
FIG 20 Swot Analysis: Cardinal Health, Inc.
FIG 21 SWOT Analysis: CANON, INC.
FIG 22 SWOT Analysis: Clarity Pharmaceuticals Ltd
FIG 23 SWOT Analysis: Koninklijke Philips N.V.
FIG 24 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 25 SWOT Analysis: TELIX PHARMACEUTICALS LIMITED
FIG 26 SWOT Analysis: ABX advanced biochemical compounds GmbH